SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed to: 6/6/08 ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/20/08 Bright Horizons Family Solut… LLC SC 13E3/A¶ 2:148K Bright Horizons Family Solut… LLC Bowne of Atlanta Inc/FA |
Document/Exhibit Description Pages Size 1: SC 13E3/A Bright Horizons Family Solutions, Inc. HTML 101K 2: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 41K
Response Letter to the SEC |
Re:
|
Bright Horizons Family Solutions, Inc. | |
Schedule 13E-3 | ||
Filed February 19, 2008 | ||
File No. 005-54461 | ||
Preliminary Proxy Statement on Schedule 14A | ||
Filed February 19, 2008 | ||
File No. 000-24699 |
1. | Please provide your analysis as to why you do not believe the Rollover Holders/Interested Directors should be named as filing persons on the Schedule 13E-3. For guidance, we refer you to Section II.D.3 of the Current Issues Outline dated November 14, 2000 available on our website at www.sec.gov. The analysis should explain why you do not believe the proposed transaction with Bain is being conducted on behalf of the Rollover Holders. In this regard, we note your disclosure of the Rollover Holders’ interest in participating in a leveraged buyout by a financial sponsor, as well as your disclosure of Bain’s history with the Company and the special committee’s willingness to consider a transaction with Bain, at a “compelling price . . . without fully exploring other potential sale opportunities.” | |
RESPONSE: We respectfully advise the Staff that the filing persons have considered the issue of whether any of the Company’s directors or executive officers (other than Joshua Bekenstein, who is already a filing person) should be named as a filing person on the Transaction Statement. Consistent with the Staff’s views expressed in Section II.D.3 of the Current Issues Outline dated November 14, 2000 (the “Outline”), this assessment was based on a review of the facts and circumstances at the time of filing and the applicable Commission rules and guidance, including Rule 13e-3 under the Exchange Act and the Outline. The filing persons have concluded that no directors or executive officers of the Company other than Mr. Bekenstein should reasonably be characterized as affiliates of the Company that are participating, directly or indirectly, in the transaction and, therefore, that no additional directors or executive officers of the Company should be named as filing persons. | ||
In the Outline, the Staff noted that it “consistently has taken the position that members of senior management of the issuer that is going private are affiliates of that issuer.” However, the Staff also noted in the Outline that the question of whether a particular affiliate of an issuer is engaged in a going-private transaction is an issue separate from the determination that such person is an affiliate and depends on all of the relevant facts and circumstances of the transaction. The Outline provides that an important aspect of the Staff’s analysis of this issue is whether the issuer’s management ultimately would (i) hold a material amount of the surviving corporation’s outstanding equity securities, (ii) occupy seats on the surviving corporation’s board of directors in addition to senior management positions and (iii) otherwise be in a position to “control” the surviving corporation within the meaning of Rule 12b-2 under the Exchange Act. We discuss each of these factors in greater detail below. |
2. | Please note that each filing person must individually comply with the filing, dissemination and disclosure requirements of Schedule 13E-3. Therefore, you will need to revise the disclosure to include all of the information required by Schedule 13E-3 and its instructions for each new filing person added in response to the previous comment. For example, include a statement as to whether each new filing person believes the Rule 13e-3 transaction is fair to unaffiliated security holders and an analysis of the material factors upon which the filing person relied in reaching such a conclusion. | |
RESPONSE: We respectfully refer the Staff to our response to Comment #1 above for an explanation of why we believe no other filing persons should be named in the Transaction Statement. |
3. | Please disclose in this section the number and percentage of the Company’s Common Stock held by Rollover Holders, and the number and percentage held by the directors and executive officers as a group. | |
RESPONSE: We respectfully refer the Staff to our response to Comment #1 above and to page 5 of the Proxy Statement, where it is stated that (i) discussions between Bain and Mr. Lissy on behalf of the Interested Directors (other than Mr. Bekenstein) and the Company’s management team regarding the possibility of post-closing employment arrangements, compensation, board representation or equity investment in the surviving corporation following the merger have only just been authorized following the expiration of the “go-shop” period, (ii) no such discussions have taken place as of the date of this letter and (iii) accordingly, there are no agreements between Bain or Parent and any Interested Director (other than Mr. Bekenstein) or member of the Company’s management team regarding such matters. As a result, there are, as yet, no confirmed Rollover Holders with respect to whom the disclosure sought in the Staff’s comment can be made. However, the number and percentage of Bright Horizons securities held by the directors and executive officers as a group have been added to the disclosure on page 5 of the Proxy Statement in accordance with the Staff’s comment. |
4. | We refer to your disclosure on page 19. Please explain in greater detail, quantifying to the extent possible, the “compelling price” proposal from Bain the special committee would have been prepared to consider without fully exploring other sale opportunities. |
5. | We refer to your disclosure on page 24. Please disclose the criteria used by the special committee to narrow the list of financial sponsors to contact, and tell us why the special committee chose not to explore a broader sales process. | |
RESPONSE: The disclosure on page 24 of the Proxy Statement has been modified to address the Staff’s comment. As noted in the modified disclosure on page 24 and on page 19 of the Proxy Statement, the special committee’s decision to approach certain financial sponsors was motivated by (i) concerns relating to the risks of disclosing sensitive Company information to competitors, (ii) concerns that a lack of confidentiality could result in speculation regarding the impact of a sale transaction on the Company’s operations, thereby adversely impacting the Company’s relationship with its employees and clients, as well as parents of children enrolled at the Company’s facilities, and (iii) the greater likelihood that financial sponsors would have interest in making an acquisition proposal. |
6. | Please include an update of the “go-shop” process, including the number and types of entities contacted by Evercore and Goldman Sachs to date, the criteria used to identify these entities and the results of these inquiries. | |
RESPONSE: We respectfully refer the Staff to page 29 of the Proxy Statement, where an update on the status of the “go-shop” process has been added to address the Staff’s comment. |
7. | Please expand to disclose the status of the negotiations between Bain and the Rollover Holders regarding their participation in the proposed transaction. | |
Disclose, if known, whether the Rollover Holders are anticipated to own a material equity interest in the surviving company, occupy board seats, hold senior management positions or otherwise be in a position to control the surviving company. | ||
RESPONSE: An update on the status of discussions between Bain and the Company’s management team has been added on page 58 of the Proxy Statement. As we note in our responses to Comments #1 and #3 above and in the revised disclosure on page 58 of the Proxy Statement, following the end of the “go-shop” period, Mr. Lissy was authorized by the special committee to commence discussions on behalf of the Interested Directors (other than Mr. Bekenstein) and the Company’s management team with Bain. As of the date of this letter, no such discussions have yet taken place, and there is, accordingly, no agreement between Bain or Parent and any Interested Director (other than Mr. Bekenstein) or member of the Company’s management team regarding post-closing |
8. | Please note that each filing person must conduct an Item 1014(b) analysis or expressly adopt the conclusion and analyses of the party that performed such analysis in order to fulfill its disclosure obligation. To the extent the special committee is relying on the analyses of Evercore and/or Goldman Sachs to satisfy any of its Item 1014 obligations, they must specifically adopt such analyses. See Instruction 2 to Item 1014 of Regulation M-A and Question and Answer No. 20 of Exchange Act Release No. 34-17719. | |
RESPONSE: We respectfully refer the Staff to the modified disclosure on page 32 of the Proxy Statement, where the factors considered by the special committee, and the special committee’s adoption of the analyses of Goldman Sachs and Evercore, are addressed in response to the Staff’s comment. |
9. | Please quantify the fees the affiliates of Goldman Sachs expect to receive in connection with the financing commitments and facilities that are contingent upon the consummation of the merger. | |
RESPONSE: We respectfully refer the Staff to the modified disclosure on pages 38, 53 and 55, where additional detail regarding the fees expected to be received by Goldman Sachs and its affiliates in connection with the financing commitments and facilities has been added to address the Staff’s comment. |
1. | The Company is responsible for the adequacy and accuracy of the disclosure in the filings with the Commission; |
2. | The Staff comments or changes to disclosure in response to Staff comments in the filings reviewed by the Staff do not foreclose the Commission from taking any action with respect to such filings; and |
3. | The Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely, |
||||
/s/ James H. Cheek, III |
||||
James H. Cheek, III | ||||
cc:
|
David H. Lissy, Bright Horizons Family Solutions, Inc. | |
Mary Ann Tocio, Bright Horizons Family Solutions, Inc. | ||
Elizabeth J. Boland, Bright Horizons Family Solutions, Inc. | ||
Stephen I. Dreier, Bright Horizons Family Solutions, Inc. | ||
Howard H. Lamar III, Bass, Berry & Sims PLC | ||
Laura R. Brothers, Bass, Berry & Sims PLC | ||
Creighton O’M. Condon, Shearman & Sterling, LLP | ||
Eliza W. Swann, Shearman & Sterling, LLP | ||
R. Newcomb Stillwell, Ropes & Gray LLP | ||
William M. Shields, Ropes & Gray LLP | ||
Eduardo Gallardo, Gibson, Dunn & Crutcher LLP | ||
Caroline Spector-Dicks, Gibson, Dunn & Crutcher LLP | ||
Charles E. Engros, Jr., Morgan, Lewis & Bockius LLP | ||
R. Alec Dawson, Morgan, Lewis & Bockius LLP |
This ‘SC 13E3/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/20/08 | PRER14A | ||
3/15/08 | ||||
3/12/08 | ||||
2/19/08 | PREM14A, SC 13E3 | |||
11/14/00 | ||||
List all Filings |